PCSA · Processa Pharmaceuticals, Inc. · Documents
$1.97
-0.02 (-1.01%)
At close · Sep 10
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.56M
Shares
2.79M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-04 | 2026-07-30 | |
| 8-K | 2026-07-29 | 2026-07-23 | |
| DEF 14A | 2026-06-18 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 10-K | 2026-03-18 | 2025-12-31 | |
| 8-K | 2026-02-19 | 2026-02-12 | |
| 8-K | 2026-01-07 | 2026-01-06 | |
| 8-K | 2025-12-15 | 2025-12-12 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K/A | 2025-09-16 | 2025-09-11 | |
| 8-K | 2025-09-12 | 2025-09-11 | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-25 | — | |
| 8-K/A | 2025-08-14 | 2025-08-04 | |
| DEF 14A | 2025-08-13 | — | |
| 8-K | 2025-08-08 | 2025-08-07 | |
| 8-K | 2025-08-07 | 2025-08-04 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-25 | — | |
| 8-K | 2025-07-18 | — | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-07-01 | 2025-06-27 | |
| 8-K | 2025-06-30 | 2025-06-24 | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-17 | — | |
| DEF 14A | 2025-05-12 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-02-11 | — | |
| 8-K | 2025-02-10 | 2025-02-04 | |
| 8-K | 2025-01-30 | 2025-01-27 | |
| 8-K | 2024-11-06 | 2024-10-31 | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| 8-K | 2024-10-02 | — | |
| 8-K | 2024-08-28 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-17 | 2024-07-16 | |
| 8-K | 2024-07-02 | 2024-06-28 | |
| 8-K | 2024-05-21 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | — | |
| 8-K | 2024-04-11 | — | |
| 8-K | 2024-04-04 | 2024-04-03 | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2024-02-21 | 2024-02-20 |
Showing 1–50 of 142 filings
Key facts
CIK
1533743
CUSIP
74275C403
13F (30d)
12 filings
12 filers
Visit website
Investor relations